Print

Johnson & Johnson (JNJ)'s DePuy Orthopaedics, Inc. (JNJ) Can't Dodge $8.3 Million Metal Hip Implant Verdict  
5/28/2013 8:19:08 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Johnson & Johnson and its DePuy Orthopaedics subsidiary lose a bid to dismiss a $8.3 million loss in a patient injury lawsuit over the company's recalled metal-on-metal hip implants. Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics is still responsible for an $8.3 million award to a patient who claimed the companies were responsible for injuries caused by recalled hip implants. California Judge J. Stephen Czuleger rejected DePuy's request for a new trial, maintaining the jury decision handed down in March, which found that the company's metal-on-metal implants were defectively designed.

Help employers find you! Check out all the jobs and post your resume.

//-->